Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer (Q73395687): Difference between revisions
Jump to navigation
Jump to search
Added [uk] description: наукова стаття, опублікована в лютому 2001, batch #79935 |
Changed label, description and/or aliases in es: BOT - Adding descriptions (1 languages): es |
||
| (6 intermediate revisions by 4 users not shown) | |||
| label / sq | label / sq | ||
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer | |||
| description / ast | description / ast | ||
artículu científicu espublizáu en febreru de 2001 | |||
| description / sq | description / sq | ||
artikull shkencor i botuar më 01 shkurt 2001 | |||
| description / fr | description / fr | ||
article scientifique publié en 2001 | |||
| description / es | description / es | ||
artículo científico publicado en 2001 | |||
| Property / main subject | |||
| Property / main subject: pharmacokinetics / rank | |||
Normal rank | |||
| Property / main subject: pharmacokinetics / reference | |||
Latest revision as of 09:20, 17 August 2024
scientific article published on 01 February 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer |
scientific article published on 01 February 2001 |
Statements
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer (English)
M S Gordon
K Margolin
M Talpaz
G W Sledge
E Holmgren
R Benjamin
S Stalter
S Shak